date:Aug 08, 2013
urpose was to analyze ginkgo biloba's efficacy in slowing down symptoms of dementia with patients suffering from Alzheimer's disease. The clinical tests were conducted over a period of 24 weeks, placebo-controlled and randomized. The participants averaged between 50 and 80 years of age, all suffered from dementia but none of them were at an advanced stage. Three groups were formed, the first one was given daily doses of ginkgo biloba, the second, a daily dose of a drug called donepezil, while th